Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Abciximab on the Levels of Circulating Microparticles in Patients with Acute Myocardial Infarction Treated by Primary Angioplasty

  • Cha, Jung-Joon (Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Kim, Jong-Youn (Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Choi, Eui-Young (Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Min, Pil-Ki (Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Cho, Minhee (Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Lee, Da-Lyung (Cardiovascular Product Evaluation Center, Yonsei University Health System) ;
  • Hong, Sung-Yu (Cardiovascular Product Evaluation Center, Yonsei University Health System) ;
  • Yoon, Young-Won (Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Lee, Byoung Kwon (Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Hong, Bum-Kee (Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Rim, Se-Joong (Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Kwon, Hyuck Moon (Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine)
  • Published : 2013.09.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: We investigated the effect of the additional use of abciximab during percutaneous coronary intervention (PCI) on the level of procoagulant microparticles (MPs) in patients with ST-segment elevation myocardial infarction (STEMI) who had undergone primary PCI. Subjects and Methods: In this study, we studied 86 patients with STEMI (72 men, age $58{\pm}13$) who had undergone primary PCI. The decision to administer abciximab immediately prior to PCI was left to the discretion of the operator. Blood samples for analysis of MPs were obtained from the femoral artery before and after PCI. MPs with procoagulant potential were measured using a commercial kit. The cellular origins of MPs were determined by antigenic capture with specific antibodies. Results: Procoagulant MPs captured onto annexin V were not changed significantly after PCI {$13.4{\pm}13.2$ nM vs. $13.2{\pm}16.1$ nM phosphatidylserine equivalent (PS eq), p=0.479}. Abciximab was used in 30 of 86 patients (35%) immediately prior to PCI. In patients who had undergone PCI without abciximab, no significant change in the level of MPs was observed after PCI. However, in the abciximab group, the level of circulating MPs was significantly decreased after PCI ($12.0{\pm}10.7$ nM vs. $7.8{\pm}11.7$ nM PS eq, p=0.018). Levels of endothelial- and platelet- derived MPs also showed a significant reduction after PCI in the abciximab group. Conclusion: Primary PCI with additional abciximab significantly reduced the level of procoagulant MPs regardless of their cellular origins in patients with STEMI.

Keywords

References

  1. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003;59:277-87. https://doi.org/10.1016/S0008-6363(03)00367-5
  2. Puddu P, Puddu GM, Cravero E, Muscari S, Muscari A. The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol 2010;26:140-5. https://doi.org/10.1016/S0828-282X(10)70371-8
  3. Leroyer AS, Isobe H, Leseche G, et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007;49:772-7. https://doi.org/10.1016/j.jacc.2006.10.053
  4. Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000;101:841-3. https://doi.org/10.1161/01.CIR.101.8.841
  5. Bernal-Mizrachi L, Jy W, Jimenez JJ, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003;145:962-70. https://doi.org/10.1016/S0002-8703(03)00103-0
  6. Morel O, Pereira B, Averous G, et al. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Atherosclerosis 2009;204:636-41. https://doi.org/10.1016/j.atherosclerosis.2008.10.039
  7. Min PK, Kim JY, Chung KH, et al. Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction. Atherosclerosis 2013;227:323-8. https://doi.org/10.1016/j.atherosclerosis.2013.01.032
  8. Morel O, Hugel B, Jesel L, et al. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. J Thromb Haemost 2004;2:1118-26. https://doi.org/10.1111/j.1538-7836.2004.00805.x
  9. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69. https://doi.org/10.1016/S0735-1097(00)00804-4
  10. Jy W, Horstman LL, Jimenez JJ, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004;2:1842-51. https://doi.org/10.1111/j.1538-7836.2004.00936.x
  11. Jeske WP, Walenga JM, Szatkowski E, et al. Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets. Thromb Res 1997;88:271-81. https://doi.org/10.1016/S0049-3848(97)00254-5
  12. Simon DI, Xu H, Ortlepp S, Rogers C, Rao NK. 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1. Arterioscler Thromb Vasc Biol 1997;17:528-35. https://doi.org/10.1161/01.ATV.17.3.528
  13. Gawaz M, Neumann FJ, Dickfeld T, et al. Vitronectin receptor (alpha(v) beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation 1997;96:1809-18. https://doi.org/10.1161/01.CIR.96.6.1809
  14. Yeh CH, Peng HC, Huang TF. Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis. Blood 1998;92:3268-76.
  15. Aymong ED, Curtis MJ, Youssef M, et al. Abciximab attenuates coronary microvascular endothelial dysfunction after coronary stenting. Circulation 2002;105:2981-5. https://doi.org/10.1161/01.CIR.0000019905.18467.07
  16. Bernal-Mizrachi L, Jy W, Fierro C, et al. Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol 2004;97:439-46. https://doi.org/10.1016/j.ijcard.2003.10.029
  17. Simak J, Gelderman MP, Yu H, Wright V, Baird AE. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006;4:1296-302. https://doi.org/10.1111/j.1538-7836.2006.01911.x
  18. Koga H, Sugiyama S, Kugiyama K, et al. Elevated levels of VE-cadherinpositive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005;45:1622-30. https://doi.org/10.1016/j.jacc.2005.02.047
  19. Nozaki T, Sugiyama S, Sugamura K, et al. Prognostic value of endothelial microparticles in patients with heart failure. Eur J Heart Fail 2010;12:1223-8. https://doi.org/10.1093/eurjhf/hfq145
  20. Amabile N, Heiss C, Chang V, et al. Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant 2009;28:1081-6. https://doi.org/10.1016/j.healun.2009.06.005

Cited by

  1. Predictors and Clinical Implications of Minimal ST-Segment Elevation in Patients with ST-Segment Elevation Myocardial Infarction vol.128, pp.3, 2013, https://doi.org/10.1159/000362438